These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 17572787)

  • 1. [Effect of methylphenidate on executive function for children with attention deficit hyperactivity disorder].
    Shuai L; Yang L; Cao QJ; Wang YF
    Beijing Da Xue Xue Bao Yi Xue Ban; 2007 Jun; 39(3):293-8. PubMed ID: 17572787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Executive function characteristic in boys with attention deficit hyperactivity disorder comorbid disruptive behavior disorders].
    Shuai L; Wang YF
    Beijing Da Xue Xue Bao Yi Xue Ban; 2007 Jun; 39(3):241-6. PubMed ID: 17572777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Executive function characteristic in boys with attention deficit hyperactivity disorder comorbid learning disabilities].
    Shuai L; Wang YF
    Beijing Da Xue Xue Bao Yi Xue Ban; 2007 Oct; 39(5):526-30. PubMed ID: 17940574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study of OROS-MPH and atomoxetine on executive function improvement in ADHD: a randomized controlled trial.
    Yang L; Cao Q; Shuai L; Li H; Chan RC; Wang Y
    Int J Neuropsychopharmacol; 2012 Feb; 15(1):15-26. PubMed ID: 22017969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Atomoxetine and Osmotic Release Oral System-Methylphenidate on Executive Functions in Patients with Combined Type Attention-Deficit/Hyperactivity Disorder.
    Ince Tasdelen B; Karakaya E; Oztop DB
    J Child Adolesc Psychopharmacol; 2015 Aug; 25(6):494-500. PubMed ID: 26218871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Practical executive function performance in high intelligence quotient children and adolescents with attention-deficit/hyperactivity disorder].
    He XX; Qian Y; Wang YF
    Zhonghua Yi Xue Za Zhi; 2013 Jan; 93(3):172-6. PubMed ID: 23570588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A pilot study on effect of methylphenidate on balance function of children with attention deficit hyperactivity disorder].
    Feng L; Wang YF; Cao QJ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2007 Jun; 39(3):304-9. PubMed ID: 17572789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Open-label, Self-control, Prospective Study on Cognitive Function, Academic Performance, and Tolerability of Osmotic-release Oral System Methylphenidate in Children with Attention-deficit Hyperactivity Disorder.
    Zheng Y; Liang JM; Gao HY; Yang ZW; Jia FJ; Liang YZ; Fang F; Li R; Xie SN; Zhuo JM
    Chin Med J (Engl); 2015 Nov; 128(22):2988-97. PubMed ID: 26608976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. OROS-methylphenidate efficacy on specific executive functioning deficits in adults with ADHD: a randomized, placebo-controlled cross-over study.
    Bron TI; Bijlenga D; Boonstra AM; Breuk M; Pardoen WF; Beekman AT; Kooij JJ
    Eur Neuropsychopharmacol; 2014 Apr; 24(4):519-28. PubMed ID: 24508533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of osmotic-release oral system methylphenidate on learning skills in adolescents with attention-deficit/hyperactivity disorder: an open-label study.
    Na KS; Lee SI; Hong SD; Kim JH; Shim SH; Choi J; Yang J; Lee MS; Joung YS; Kim EJ; Park JH
    Int Clin Psychopharmacol; 2013 Jul; 28(4):184-92. PubMed ID: 23587983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of extended-release methylphenidate on the ecological executive function for attention deficit hyperactivity disorder].
    Qian Y; Cao QJ; Wang YF
    Beijing Da Xue Xue Bao Yi Xue Ban; 2007 Jun; 39(3):299-303. PubMed ID: 17572788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pilot study: differential effects of methylphenidate-OROS on working memory and attention functions in children with attention-deficit/hyperactivity disorder with and without behavioural comorbidities.
    Rubio B; Hernández S; Verche E; Martín R; González-Pérez P
    Atten Defic Hyperact Disord; 2011 Mar; 3(1):13-20. PubMed ID: 21432614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Better efficacy for the osmotic release oral system methylphenidate among poor adherents to immediate-release methylphenidate in the three ADHD subtypes.
    Chou WJ; Chou MC; Tzang RF; Hsu YC; Gau SS; Chen SJ; Wu YY; Huang YF; Liang HY; Cheng H
    Psychiatry Clin Neurosci; 2009 Apr; 63(2):167-75. PubMed ID: 19335386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Characteristics of executive function in children with attention deficit/hyperactivity disorder comorbid with high functioning autism].
    Zhang SH; Wang P; Yang BR; Zhong YY; Wang YF
    Zhonghua Yi Xue Za Zhi; 2020 Aug; 100(31):2446-2451. PubMed ID: 32819061
    [No Abstract]   [Full Text] [Related]  

  • 15. Prospective, naturalistic study of open-label OROS methylphenidate treatment in Chinese school-aged children with attention-deficit/hyperactivity disorder.
    Zheng Y; Wang YF; Qin J; Wang LW; Zou LP; Jin XM; Xu T; Wang Y; Qi YL; Gong ME; Yin QY; Mai JN; Jing J; Luo XY; Ma HW; Li HB; Xie L; Li Y; Kuang GF; Yi MJ; Wang F; Zhu XH; Yao YB
    Chin Med J (Engl); 2011 Oct; 124(20):3269-74. PubMed ID: 22088519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does OROS-methylphenidate improve core symptoms and deficits in executive function? Results of an open-label trial in adults with attention deficit hyperactivity disorder.
    Fallu A; Richard C; Prinzo R; Binder C
    Curr Med Res Opin; 2006 Dec; 22(12):2557-66. PubMed ID: 17166338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effects of methylphenidate on various components of visual attention in children with attention-deficit hyperactivity disorder].
    Durukan I; Türkbay T; Cöngöloğlu A
    Turk Psikiyatri Derg; 2008; 19(4):358-64. PubMed ID: 19110977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The divergent impact of COMT Val158Met on executive function in children with and without attention-deficit/hyperactivity disorder.
    Jin J; Liu L; Gao Q; Chan RC; Li H; Chen Y; Wang Y; Qian Q
    Genes Brain Behav; 2016 Feb; 15(2):271-9. PubMed ID: 26560848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of transitioning from extended-release methylphenidate onto osmotic, controlled-release methylphenidate in children/adolescents with ADHD: results of a 3-month non-interventional study.
    Wolff C; Alfred A; Lindermüller A; Rettig K; Mattejat F; Gerwe M; Slawik L; Schäuble B
    Curr Med Res Opin; 2011; 27 Suppl 2():35-44. PubMed ID: 21787126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Open-Label, Randomized Trial of Methylphenidate and Atomoxetine Treatment in Children with Attention-Deficit/Hyperactivity Disorder.
    Shang CY; Pan YL; Lin HY; Huang LW; Gau SS
    J Child Adolesc Psychopharmacol; 2015 Sep; 25(7):566-73. PubMed ID: 26222447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.